Lawyers at Baker & McKenzie and Zelle Hofmann failed to whittle down a long-running antitrust class action against a trio of Chinese vitamin C manufacturers, leaving the case intact ahead of a scheduled trial early next year.

Michael Hausfeld hasn't wasted any time responding to a juicy wrongful termination suit filed last week by one of his former law partners, Jon King, who says he was canned after speaking out about a raft of alleged ethics violations at Hausfeld's eponymous antitrust class action firm, Hausfeld LLP.

Can Chinese companies that allegedly fixed prices for U.S. customers deflect liability by saying they acted at their government's behest? Jurors may get a chance to answer that question beginning Monday, when an antitrust class action trial against a group of Chinese vitamin manufacturers opens in U.S. district court in Brooklyn.

Yes, it's true. We are all plaintiffs now. Or nearly all of us, thanks to a pair of March 28 orders certifying two classes in the consolidated antitrust litigation against the makers of liquid crystal display screens.